UB
GSK icon

UMB Bank’s GSK GSK Stock Holding History

UMB Bank’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Buy
2,752
+135
+5% +$7.14K ﹤0.01% 879
2026
Q1 		$144K Sell
2,617
-92
-3% -$4.99K ﹤0.01% 805
2025
Q4 		$133K Buy
2,709
+414
+18% +$19.3K ﹤0.01% 817
2025
Q3 		$99.1K Sell
2,295
-204
-8% -$7.97K ﹤0.01% 871
2025
Q2 		$96K Sell
2,499
-6
-0.2% -$229 ﹤0.01% 852
2025
Q1 		$97K Sell
2,505
-141
-5% -$5.16K ﹤0.01% 773
2024
Q4 		$89.5K Buy
2,646
+50
+2% +$1.8K ﹤0.01% 724
2024
Q3 		$106K Sell
2,596
-484
-16% -$19.8K ﹤0.01% 688
2024
Q2 		$119K Sell
3,080
-2,001
-39% -$84.2K ﹤0.01% 651
2024
Q1 		$218K Sell
5,081
-880
-15% -$36.3K ﹤0.01% 551
2023
Q4 		$221K Sell
5,961
-501
-8% -$18K ﹤0.01% 559
2023
Q3 		$234K Buy
6,462
+297
+5% +$10.5K ﹤0.01% 531
2023
Q2 		$220K Sell
6,165
-134
-2% -$4.81K ﹤0.01% 568
2023
Q1 		$224K Buy
6,299
+661
+12% +$23.1K ﹤0.01% 552
2022
Q4 		$198K Buy
+5,638
New +$188K ﹤0.01% 587
2022
Q3 		– Sell
-21,679
Closed -$1.18M – 1844
2022
Q2 		$1.18M Sell
21,679
-6,789
-24% -$375K 0.02% 347
2022
Q1 		$1.55M Sell
28,468
-334
-1% -$18.1K 0.02% 330
2021
Q4 		$1.59M Buy
+28,802
New +$1.5M 0.02% 333

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

UMB Bank's GSK Position: Q2 2026 in Review

UMB Bank increased its GSK (GSK) stake by 5.2% in Q2 2026, buying an estimated $7.14K and bringing the position to 2,752 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

UMB Bank first reported a position in GSK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.59M in Q4 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • UMB Bank held 2,752 shares of GSK worth $144K as of Q2 2026.
  • UMB Bank bought 135 GSK shares in Q2 2026, an estimated $7.14K.
  • GSK made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #879 holding.
  • UMB Bank first reported a position in GSK in Q4 2021 and has held it in 18 quarters since.
  • UMB Bank's GSK position peaked at $1.59M in Q4 2021.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.